Skip to content

Real World Study of Diagnosis and First-line Treatment Among Patients With Cancer of Unknown Primary in China

Real World Study of Diagnosis and First-line Treatment Among Patients With Cancer of Unknown Primary in China

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04952103
Enrollment
200
Registered
2021-07-07
Start date
2021-06-18
Completion date
2024-06-18
Last updated
2021-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer of Unknown Primary Site

Brief summary

This study is a prospective, real world study.The objective is to observe the diagnosis and first-line treatment of Chinese patients with cancer of unknown primary, and collect the clinicopathological characteristics, treatment outcomes, survival and other data of the patients.

Interventions

OTHERno intervention

The patient's treatment is determined by the physician in charge according to the patient's clinical situation and relevant guidelines, without additional intervention.

Sponsors

Fudan University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Had a diagnosis of cancer of unknown primary (CUP) after a standard evaluation . * Prepared to receive first-line therapy for CUP

Exclusion criteria

* Patients who had previously received systemic therapy for CUP * Previous history of other cancers, except cervix cancer or basal cell carcinoma of the skin that has been cured * The investigator considered that there were contraindications to treatment or were not appropriate to participate in this study

Design outcomes

Primary

MeasureTime frame
Progression-free survival (PFS)8 months

Countries

China

Contacts

Primary ContactXin Liu
jeanettexin@hotmail.com13761503356

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026